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Abstract
Background: Coexistent lung cancer and pulmonary tuberculosis is an urgent problem of thoracic
surgery presenting a challenging task for diagnosis and surgical treatment.
Materials and methods: From 1990 to 2005, 2218 patients with lung cancer underwent surgical
treatment in Department of Thoracic Surgery and Oncology, Institute of Oncology, Vilnius
University. In 46 (2.1%) patients coexistence of lung cancer and tuberculosis was found. Central
lung cancer was diagnosed in 37 (80.4%) and peripheral – in 9 (19.6%) patients. Epidermoid cancer
was diagnosed in 24 (52.2%) patients, adenocarcinoma – in 10 (21.7%) and adenoepidermoid
carcinoma – in 12 (26.1%) patients. Stage I cancer was diagnosed in 12 (26.1%), stage II – in 11
(23.9%), and stage IIIA – in 23 (50%) patients.
Results: Pneumonectomy was performed in 18 (39.2%), lobectomy in 10 (21.7%), bilobectomy in
10 (21.7%), segmentectomy in 8 (17.4%) patients. Postoperative surgical complications were
observed in 9 (19.5%) patients, non-surgical complications occurred in 19 patients (41.3%). Six
patients (13.04%) died. Combined treatment was applied to 23 (50%) patients.
Conclusion: Coexistence of tuberculosis and lung cancer in thoracic surgery is fairly rare. This
combination was diagnosed only in 46 cases (2.1%) out of 2218 operated lung cancer patients.
Epidermoid carcinoma and stage IIIA disease was diagnosed in 50% of patients. Postoperative
surgical complications occurred in 9 patients (19.5%) with lung cancer and tuberculosis. Six patients
(13%) died in postoperative period. Surgery is the method of choice in treatment of combination
of tuberculosis and lung cancer. Median survival of these patients was 28 ± 2 months.
Background
Coexistence of tuberculosis and lung cancer has remained
controversial since the middle of 19th century. Some scien-
tists stated that tuberculosis promotes development of
cancer; others assert that tuberculosis and cancer are
antagonists. Classics of pathologic anatomy P. Virchov
and K. Rokitansky were advocates of latter statement
(1854). As the diagnostics of lung diseases improved, sci-
entists began to believe that post tuberculosis sclerotic
changes facilitate development of cancer ("cancer in the
scar") [1,2]. At present it is clear that tuberculosis and
other chronic lung diseases increase the risk of lung cancer
[1-4].
Well-known pathologists N. A. Dacosta and G. G. Kinare
(1991) on the grounds of numerous autopsies found out
that combination of lung cancer and tuberculosis of lung
was found in 13.1% of patients [4]. Watanabe et al., pub-
lished analysis of 758 of lung cancer, and coexistence of
cancer and tuberculosis was found in 2.1% of cases [5,6].
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Some research showed that scars, which remain after heal-
ing of tuberculoses' lesion, could cause development of
lung cancer [7]. Some authors point out that increasing
incidence of lung diseases is associated with increased
incidence of lung cancer and therefore there should be
oncological watchfulness in follow-up of patients with
lung diseases or tuberculosis [8-10].
Patients and methods
Between 1990 and 2005, 2218 patients with lung cancer
underwent surgical treatment in the Department of Tho-
racic Surgery and Oncology, Institute of Oncology, Vilnius
University. In 46 (2.1%) patients coexistence of lung can-
cer and tuberculosis was diagnosed. Following methods
of diagnostics were used: chest X-ray, computed tomogra-
phy (CT), bronchoscopy, bacterioscopic, bacteriologic
and cytological investigation of sputum, pathological
investigation.
Diagnosis of coexistence of cancer and tuberculosis was
established before surgery in 18 (39.1%) patients in other
28 (60.8%) the diagnosis was established after pathologi-
cal examination of resected specimens. Despite adequate
antituberculosis treatment of all 46 pts (4–5 months of
treatment with drugs of choice) in 15 (32.6%) patients
mycobacterium was found in sputum before surgery
(TM+).
Roentgenological, tomographical and pathological meth-
ods revealed coexistence of cancer and tuberculosis in the
foci of previous tuberculosis in 32 (69.5%) patients, in 8
(17.4%) patients. changes were found unilaterally to
tuberculosis, and in 6 (13.0%) changes were in the intact
lung. Cases by stage are presented in Table 1.
Operations were performed according to criteria men-
tioned above and tumor extent is presented in Table 2.
It should be noted that such traumatic operations were
performed because of clinical situation. Pleural adhe-
sions, fibrosis and sclerosis of lung tissue and scarry
changes are usually observed in tuberculosis patients.
Pathistological investigation of removed specimen
revealed that fibrocavernous tuberculosis in 15 (30.5%)
patients, infiltrative in 12 (26.0%), disseminated in 5
(10.8%) and pneumosclerosis due to tuberculosis (large
calcinates, hard foci, solitary and multiple tuberculomas,
lung cirrhosis) in 14 (30.6%) patients respectively. Mor-
phological type of cancer is presented in Table 3.
In 12 (26.0%) patients with progressive lung cancer that
was located in the region of post tuberculosis changes we
observed destruction of tumor with destruction of lung
tissue and tuberculosis dissemination around the tumor.
Adjuvant treatment was given to 23 (50%) patients: Of
these, 12 (52%) received radiation therapy (42 Gy), 11
(48%) received chemotherapy (etoposide+cisplatinum ×
6 cycles), 5 (21.7%) patients from this group later
received antituberculosis treatment because of exacerba-
tion of tuberculosis.
Results
Type and extent of operation depended on general status
of patient, concomitant disease, extent of cancer and
tuberculosis. Clinical type and phase of tuberculosis as
well as anatomical, tomographical and histological type
of lung cancer were established by roentgenological and
morphological investigations.
For example this 58-year-old man with the history of
chronic bronchitis for about 30 years of duration was
diagnosed with tuberculosis 5 months ago. Treatment
with five basic antituberculosis medications was started.
Treatment was declared ineffective after the bacteriologi-
cal and bacterioscopical investigations revealed tubercu-
losis mycobacterium in sputum (TM+). Infiltrative
Table 2: Operations performed in patients with coexistent lung cancer and tuberculosis






Table 1: Cases with coexistent cancer and tuberculosis by stage
Stage No of patients %
Stage I (T1-2N0M0) 12 26.1
Stage II (T2N1M0) 11 23.1
Stage III (T3N1-2M0) 23 50
Total 46 100World Journal of Surgical Oncology 2007, 5:22 http://www.wjso.com/content/5/1/22
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changes in the upper lobe of left lung were found at x-ray
examination (Figure 1). Figure 2 shows chest CT scan with
pulmonary bullous in right upper lobe. Brush-biopsy was
performed during fiber optic bronchoscopy, and cells of
epidermoid cancer were found. Patient underwent sur-
gery. Left upper lobectomy was performed. Pathological
investigation revealed infiltrating epidermoid carcinoma
of lung (pT1N0M0). Figure 3 shows macroview of postop-
erative specimen. Because of radical surgery no anticancer
treatment was prescribed. Treatment with antituberculo-
sis medications was performed. Figure 4 shows morpho-
logical changes in resected specimen.
Microscopy of the resected specimen showed cancer cells
against the background of tuberculosis changes. This spec-
imen confirmed coexistence of tuberculosis and lung can-
cer, and in this case one process stimulates another. This
could explain ineffectiveness of antituberculosis treat-
ment. Exacerbation of tuberculosis influenced incidence
of postoperative complications.
Postoperative complications occurred in 28 (60.8%) of
our patients. From these 9 (19.5%) were surgical compli-
cations (Table 4). Rest 19 (41.3%) complications were
associated with chronic pneumonia (3 patients), bron-
chial asthma (3 patients), COPD (9 patients) and heart
failure (4 patients).
Six patients (13.4%) died due to postoperative complica-
tions. Postoperative radiotherapy or chemoradiotherapy
was applied in 23 (50%) patients with inactive tuberculo-
sis. From these 12 (52%) patients with pT3N1M0 were
treated with regional radiotherapy. The other 11 (48%)
patients with T3N2M0 were treated with regional radio-
therapy and chemotherapy (6 courses of etoposide + cis-
platinum). Tuberculosis specialists and oncologists
Postoperative specimen Figure 3
Postoperative specimen. Tumor occludes lumen of bron-
chus (1) and tuberculosis(2).
X-ray of the thorax Figure 1
X-ray of the thorax. Infiltrative changes are observed in 
the left upper lobe.
Table 3: Morphology of cancer in operated patients
Morphology of tumor No of patients %
Epidermoid carcinoma 24 52.2
Adenocarcinoma 10 21.7
Epidermoid adenocarcinoma 12 26.1
Total 46 100
Chest CT Figure 2
Chest CT. There is pulmonary bulla in the right S1 segment, 
and focus of mottled opacity 7,5 × 2,5 cm with infiltration 
around it.World Journal of Surgical Oncology 2007, 5:22 http://www.wjso.com/content/5/1/22
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conducted further follow-up. Median survival of these
patients was 28 ± 2 months.
Discussion
Diagnosis of lung cancer in patients with tuberculosis or
with residual effects of tuberculosis possesses some pecu-
liarities. These depend on variety of clinical symptoms
that occurs due to coexistence of diseases (which is called
mix), clinical course and site of cancer (both processes are
located in the same region or separately). When cancer
develops against the background of active tuberculosis,
common symptoms are worsening of patients' general sta-
tus (fever, signs of intoxication, shortness of breath and
often sputum with touch of blood occur). Investigations
of show that x-ray picture in these cases is different: foci of
infiltration of various size, atelectasis, hypoventilation of
various parts of lungs, and foci of destruction with forma-
tion of caverns is seen. Bacteriological analysis shows
presence of tuberculosis mycobacterium, which was not
previously detected. As shown earlier in cases, when new
signs not typical for tuberculosis occur there should be
dynamic analysis of roentgenological signs and bacterio-
logical analysis. In case of ineffective specific treatment
coexistence of lung cancer and tuberculosis should be pre-
sumed [2].
According to Drent (1994), Tamura (1999), and Watan-
abe (1999) post tuberculosis scars deform blood and lym-
phatic vessels [3,5,6]. Lymphostasis, conditions for
deposit of carcinogens and development of malignant
process occur. In patients with coexistence of tuberculosis
and lung cancer diagnosis is difficult. In such cases bron-
choscopy, CT and transthoracic lung biopsy should be
performed. If diagnosis is unclear after all performed diag-
nostic tests, operation is necessary.
In our series of 2218 operated patients, 46 (2.1%) cases of
coexistence of lung cancer and tuberculosis were found. It
is possible that tuberculosis of lung prepare conditions for
the development of lung cancer. We think that patients
with coexistence of lung cancer and tuberculosis could be
divided into three groups:
1. Tuberculosis and lung cancer are unrelated
2. There is relation between both processes, post tubercu-
losis changes, deformation of bronchi and alveoli, epithe-
lial dysplasia are risk factors for lung cancer.
3. In lung cancer progression old foci of tuberculosis reac-
tivate and dissemination of tuberculosis mycobacterium
occur.
We agree with scientists who affirm that in case of new
lung symptoms patients with tuberculosis after recovery
should undergo follow-up periodically. In order to diag-
nose lung cancer early, chest x-ray, bronchoscopy and
cytological investigation of sputum should be performed.
It should be noted that mycobacterium was found in spu-
tum again in part of patients with history of tuberculosis.
It was thought to be recurrence of tuberculosis and these
patients received recurring antituberculosis treatment.
However, when careful checkup was performed in cases of
worsening general status in patients with history of tuber-
culosis, usually lung cancer was diagnosed. Therefore peri-
odic checkup of these patients is necessary.
Conclusion
Coexistence of tuberculosis and lung cancer is obvious,
although it is rare in the practice of thoracic surgery. In
most cases epidermoid cancer was diagnosed (52.2% of
patients). Stage IIIA lung cancer was diagnosed in 50% of
patients. Postoperative surgical complications occurred
for 9 (19.5%) patients. 19 (41.35%) non-surgical compli-
cations occurred due to heart and lungs chronic diseases.
Six patients (13.04%) died. Surgery is treatment of choice
in cases of coexistence of tuberculosis and lung cancer. A
good median survival is normally achievable.
Table 4: Postoperative surgical complications
Postoperative surgical complications No. of patients %
Insufficiency of suture of bronchial stump 3 6.5
Subcutaneous emphysema 4 8.7
Postoperative wound infection 2 4.3
Total 9 19.5
Microview of resected specimen H&E stain, ×20 Figure 4
Microview of resected specimen H&E stain, ×20. 
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